Searched for
TORIPALIMAB
Dr Reddy's Laboratories shares rise 2% after launching drug to treat nasopharyngeal cancerDr Reddy's Laboratories has launched toripalimab, an immune oncology drug for adults with recurrent or metastatic nasopharyngeal carcinoma ...29 Nov, 2024, 10.15 AM IST- Stocks in news: RIL, PC Jeweller, Dr Reddy's, Enviro Infra Engineers, HDFC Life, SBI LifeLeading exchange BSE has revised the price band of Adani Total, Paytm, LIC, Jio Financial, Angel One, Zomato among 55 stocks to 10% with ef...29 Nov, 2024, 06.56 AM IST
- Dr Reddy's launches drug for neck, head cancerDr Reddy's Laboratories launched toripalimab, an immune oncology drug for adults with a rare form of head and neck cancer, in India. This d...28 Nov, 2024, 11.00 PM IST
- Dr Reddy's launches novel cancer therapy Toripalimab in IndiaDr. Reddy’s has launched Toripalimab, a novel immuno-oncology drug, in India for treating recurrent or metastatic nasopharyngeal carcinoma ...28 Nov, 2024, 06.16 PM IST
- Dr Reddy's launches immuno-oncology drug Toripalimab in India for treating nasopharyngeal carcinomaDr. Reddy's Laboratories launched Zytorvi (Toripalimab), a novel immunotherapy drug for recurrent or metastatic nasopharyngeal carcinoma (N...28 Nov, 2024, 11.45 AM IST
Load More
